ARTICLE SUMMARY:
Novel FDA Device Approvals, Breakthrough Designations, Class I Recalls, Warning Letters, and new Diagnostic Emergency Use Authorizations in October 2024. Updated October 31.
A roundup of FDA’s actions in October 2024.
FDA Output, October 2024
×
